Harrow, INC. (HROW) SEC Filings — 2024
22 SEC filings for Harrow, INC. (HROW) in 2024.
Filings
- Harrow, INC. SC 13G/A Filing — SC 13G/A · Dec 5, 2024
- Harrow, Inc. Q3 Sales Decline to $38.7M — 10-Q · Nov 14, 2024
- Harrow, Inc. Files 8-K on Senior Notes Agreements — 8-K · Oct 28, 2024
- Harrow, INC. SC 13G/A Filing — SC 13G/A · Oct 8, 2024
- Harrow, Inc. Files 8-K Report — 8-K · Sep 9, 2024
- Harrow, Inc. Q2 2024 10-Q Filing — 10-Q · Aug 7, 2024
- Harrow, Inc. Appoints New Auditor, BDO USA, P.A. — 8-K · Jun 26, 2024
- Harrow, Inc. Seeks Shareholder Vote Approval — 8-K · Jun 17, 2024
- Harrow, Inc. Files 10-Q for Q1 2024 — 10-Q · May 13, 2024
- Harrow, Inc. Amends Stake in Eton Pharmaceuticals — SC 13D/A · Apr 30, 2024
- Harrow, Inc. Files Definitive Additional Materials — DEFA14A · Apr 26, 2024
- Harrow Inc. Debt Exchange Offer Early Results — 8-K · Mar 21, 2024
- Harrow, Inc. Closes $125M Senior Notes Offering — 8-K · Mar 20, 2024
- Harrow, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
- HARROW, INC. Files 8-K, Details Existing Securities — 8-K · Feb 15, 2024
- Harrow, INC. SC 13G Filing — SC 13G · Feb 13, 2024
- Harrow, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Opaleye Management Reports 8.7% Stake in Harrow, Inc. — SC 13G/A · Feb 9, 2024
- BlackRock Discloses Passive Stake in Harrow, Inc. Common Stock — SC 13G · Jan 29, 2024
- HARROW Confirms Nasdaq Listings for Common Stock, Senior Notes — 8-K · Jan 29, 2024
- Private Capital Management Discloses Passive Stake in Harrow, Inc. — SC 13G · Jan 9, 2024
- HARROW Reports Agreement Termination, Leadership Changes, Ethics Update — 8-K · Jan 3, 2024